Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.
about
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisSubcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathiesRapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodiesThe pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathiesNo longer falling on deaf ears: mechanisms of degeneration and regeneration of cochlear ribbon synapses.Schwann cells are activated by ATP released from neurons in an in vitro cellular model of Miller Fisher syndrome.Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.Mitochondrial alarmins released by degenerating motor axon terminals activate perisynaptic Schwann cellsAnti-ganglioside antibodies in amyotrophic lateral sclerosis revisitedAnti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosisSnake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular JunctionAnti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis.Animal models of autoimmune neuropathy.Autoimmune neuropathies: insights from animal models.The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy.Pathophysiology of immune-mediated demyelinating neuropathies-part I: neuroscience.Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.Hepatitis E virus and neurological injury.Guillain-Barré syndrome: a century of progress.Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice.Canomad: report of a case with a 40-year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade?Limb motor nerve dysfunction in Miller Fisher syndrome.Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice.
P2860
Q22251013-781D8271-B447-446F-9D44-0B5CA75267F2Q26745685-F8A1D0F9-5C8F-434D-81F1-79C2E9BA1BFEQ26864907-5A8F6373-0F9E-4742-BB0C-AE315ABFA75EQ27004097-5277758D-8441-4230-AFD0-A03E7193317DQ28088712-E084EAD1-B608-498A-BFB7-47ABCF209B18Q33746256-97A874FF-7CC9-464D-B91E-D85A7A20F29BQ35016370-B486D1A8-E0B6-4AFB-AFEB-C0A4CE1FF9E4Q35062594-8678E6A4-756F-42A0-A887-7DAE8D22726BQ35416888-F80E73F8-F421-46BB-A18D-2E4E02755A09Q35780245-3C236DD7-EA1A-427F-84F9-C4F2AE0D33CDQ36104857-649A931C-CB01-4D7F-ADCF-E216ED6BC30CQ36401493-104937AE-AF00-48C8-8A7F-8A0F9B4B68A0Q36967702-63CC7A6A-85FE-4CE2-A3F9-51126BB0EA48Q37655234-B77EEB61-4B64-4212-92BF-673F61DA6052Q38006760-85D8CC01-E7C4-434E-B16D-893AD3F8D185Q38070878-A488C9DB-331A-4672-8476-40403F3D3D74Q38134344-96E6D790-1AB8-47E9-B5ED-CB1169CA341AQ38137792-070256FD-265D-4E0C-99F6-90328AAEBFF6Q38270717-BDEBAC6E-9EEE-42DC-A2ED-36247D80A918Q38681788-4BFDA72C-5C8F-4755-9EF2-D073A358799FQ39011456-24DEC08C-0B65-4D9A-AC18-7DC08D465362Q41189967-D9A24DBB-7547-4D9E-ADAC-BFD51C8674E1Q41249640-5ACF2BCB-B2FD-478F-8E0B-7E3CDAAE3F6EQ45152317-17D7CD15-A9E3-4884-80B3-0B604FDD4347Q45769387-FD5D78E6-49FA-48F4-851D-D870D0304764Q48180410-ABDEB253-EF77-41C5-9C20-66217B2A12C5
P2860
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiological actions of ...... at the neuromuscular junction.
@en
Pathophysiological actions of ...... at the neuromuscular junction.
@nl
type
label
Pathophysiological actions of ...... at the neuromuscular junction.
@en
Pathophysiological actions of ...... at the neuromuscular junction.
@nl
prefLabel
Pathophysiological actions of ...... at the neuromuscular junction.
@en
Pathophysiological actions of ...... at the neuromuscular junction.
@nl
P2860
P1476
Pathophysiological actions of ...... at the neuromuscular junction.
@en
P2093
Hugh J Willison
Jaap J Plomp
P2860
P304
P356
10.1113/JPHYSIOL.2009.171702
P407
P577
2009-06-29T00:00:00Z